Richard Milner, Ph.D. publishes on his finding that, Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis Progression by Enhancing Vascular Integrity and Suppressing Microglial Activation

Dr. Milner’s recent study aimed to clarify the therapeutic potential of activated protein C (APC) in the experimental autoimmune encephalomyelitis (EAE) model of Multiple Sclerosis (MS). His study showed that APC suppressed clinical progression of EAE and mechanistic studies revealed that this was due, in part, by enhancing vascular integrity and suppressing microglial activation. Together, these studies demonstrate strong therapeutic potential for APC in the treatment of inflammatory demyelinating diseases such as MS.

We need your help

Our research programs are funded primarily by grants from the National Institutes of Health (NIH). Private donations help to accelerate the progress of research through the purchase of laboratory supplies and equipment or the recruitment of additional laboratory personnel. Thank you!

Donate Now